20 August 2024
20 August 2024
The deal grants Edwards Lifesciences almost complete ownership of JC’s transcatheter aortic valve replacement system.
The project aims to support standard adoption of advanced imaging techniques and empower clinicians to make more informed decisions.
The recall poses a significant risk to Tandem’s reputation in the insulin pump market.
The clearance covers surgical wounds up to 25cm, potentially unlocking the orthopaedic market for the company.
SyMRI 12 is designed to provide a comprehensive suite of contrast-weighted images and quantitative data from a single rapid scan.
Enovis’ STAR Patient Specific Instrumentation, when combined with the new e+ Polyethylene, forms the STAR+ Experience.
The Nidra TOMAC therapy received FDA marketing authorisation as a breakthrough device in the US last year.
While Neuralink has implanted its Telepathy device in two patients, other tech companies are further along in their clinical journey.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
